KELUN-BIOTECH ANNOUNCES RESULTS FROM THE SKB264-II-06/MK-2870-002 STUDY OF SACITUZUMAB TIRUMOTECAN (SAC-TMT) IN GYNECOLOGIC ONCOLOGY PRESENTED AT 2026 SGO

Reuters · 2d ago

Please log in to view news